A phase II study of oxaliplatin and capecitabine in patients with unresectable cholangiocarcinoma, including carcinoma of the gallbladder and biliary tract

Trial Profile

A phase II study of oxaliplatin and capecitabine in patients with unresectable cholangiocarcinoma, including carcinoma of the gallbladder and biliary tract

Completed
Phase of Trial: Phase II

Latest Information Update: 31 Jul 2012

At a glance

  • Drugs Capecitabine; Oxaliplatin
  • Indications Biliary cancer; Cholangiocarcinoma; Gallbladder cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 27 Oct 2009 Actual end date (1 May 2009) added as reported by ClinicalTrials.gov.
    • 27 Oct 2009 Actual patient number (44) added as reported by ClinicalTrials.gov.
    • 27 Oct 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top